EarlyGuard AI Cancer Risk Analysis
On the EarlyGuard website, try a limited, profile-based cancer risk example. It uses only the health information you choose to enter and applicable published risk-assessment methods, then explains what the available result can—and cannot—tell you.
Important distinction
This website profile check is not the full EarlyGuard assessment. It does not use EarlyGuard test-kit measurements, changes over time or repeated biomarker history, and it does not invent or infer kit data.
Full EarlyGuard solution: In clinical development, the broader EarlyGuard concept combines EarlyGuard-developed AI models with biomarker quantities measured using EarlyGuard test kits, changes over time and repeated test history, personal medical and family history, profile information, recorded behavioral/lifestyle history, and applicable published methods to produce risk scores. This capability description does not represent commercially approved tests or proven efficacy.
These tools provide statistical estimations, not medical diagnoses. Always consult a healthcare professional for clinical advice.
How the Website Example Works
A straightforward process for sharing relevant information you enter, understanding what the limited website example assesses, and receiving a report to discuss with your clinician.
1. Account & Profile
Create an account and add the general health information needed for your report.
2. Health Information
Answer questions about your health, history, and other factors relevant to the assessment.
3. Review & Consent
Review what will be assessed, its limitations, and provide explicit health data consent.
4. Clear Explanation
Receive a plain-English explanation of the available result and the information considered.
5. Report & Next Steps
Use your report to prepare for an informed conversation with your clinician.
The website example and the full EarlyGuard solution
The public website experience is deliberately limited: it uses only the profile information you enter and applicable published risk methods. Separately, the full EarlyGuard solution is in clinical development and is being designed to combine EarlyGuard-developed AI models with biomarker quantities measured using EarlyGuard test kits, changes over time and repeated test history, personal medical and family history, profile information, and recorded behavioral/lifestyle history to produce risk scores. It is not presented here as a commercially approved test or as having proven efficacy.
Published methods are validated only within their original study populations and settings. That validation does not validate the whole EarlyGuard platform or establish that a method applies to every user or country.
Website profile example
A limited public experience
See an available profile-based estimate in context, including what the result describes and the period it covers. This website example uses only information you enter and applicable published methods.
- No EarlyGuard test-kit measurements, repeated biomarker history, or invented kit data are used.
- This profile check is not the full EarlyGuard assessment or a diagnostic test.
Full EarlyGuard solution
A capability in clinical development
The full solution is being developed to combine EarlyGuard-developed AI models with biomarker quantities measured using EarlyGuard test kits, changes over time and repeated test history, personal medical and family history, profile information, recorded behavioral/lifestyle history, and published risk methods.
- The intended capability is to use these combined inputs to produce risk scores.
- Clinical development does not imply commercially approved tests or proven efficacy.
Get a report you can use
Clear results and important context
Keep the website result, limitations, and published method details together so you can return to them when speaking with a clinician.
- Download a structured report for your personal records.
- Find published method and source details in your personal report.
Prepare for a clinician conversation
Information to discuss, not instructions
A report can help you organize questions and understand which topics may need follow-up with a healthcare professional.
- Bring the report to a consultation if you choose.
- Follow your clinician's advice about screening, testing, and care.
Strict Medical Limitations
Not a diagnostic test: The public website profile check provides statistical information based on population data and the information you enter. It cannot diagnose cancer, confirm the absence of cancer, or replace professional medical evaluation.
Website scope and data: This website experience is limited to user-entered profile information and applicable published methods. It does not use EarlyGuard test-kit measurements, changes over time or repeated biomarker history, and it does not invent or infer kit data. It is not the full EarlyGuard assessment.
When a result is available: The website example is intended for defined populations and relies on the information you provide. If required information is missing or your profile is outside the applicable population, a result will be unavailable rather than guessed. An unavailable result, or a result that does not indicate elevated risk, cannot confirm the absence of cancer.
The role of AI: In this website experience, AI is scoped to organizing the information you enter and explaining an available published-method result in plain language. It does not diagnose, replace clinical judgment, invent accuracy, or grant medical approval. Separately, EarlyGuard-developed AI models are part of the broader full-solution capability concept in clinical development; that does not imply commercially approved tests or proven efficacy. Published method and source details are provided in your personal report.
Published method limitations: A published method is validated only within its original study populations and settings. That validation does not validate the whole EarlyGuard platform or establish that the method applies to every user or country.
Prostate assessments: If included, a prostate assessment relates to outcomes from a current, clinician-indicated biopsy. It is not a prediction of future prostate cancer risk and should be considered with the clinician recommending the biopsy.
Consent and Privacy: Participation requires explicit health data consent prior to any calculation. Marketing, product information, and announcement consents are entirely separate, completely optional, and editable at any time within your profile. They are never required to access your risk analysis.
Frequently Asked Questions
Are these assessments diagnostic?
No. The website profile check provides statistical information based on population evidence and the profile information you provide. It is not a diagnostic test, cannot diagnose cancer or confirm that cancer is absent, and does not replace medical evaluation. Always consult a healthcare provider for medical interpretation.
What information do I enter?
For this public website example, you enter the general health and profile information relevant to the available published method, which may include personal and family history, prior results, lifestyle information, and other profile details. You do not provide EarlyGuard test-kit measurements here, and the website does not invent or infer them. The assessment will explain what information was considered in your personal report.
How is the website example different from the full EarlyGuard solution?
The website is a limited profile-based example that uses only information you enter and applicable published methods. It is not the full EarlyGuard assessment and does not use kit measurements or longitudinal biomarker analysis. The broader EarlyGuard solution is in clinical development and is being designed to combine EarlyGuard-developed AI models with biomarker quantities measured using EarlyGuard test kits, changes over time and repeated test history, personal medical and family history, profile information, recorded behavioral/lifestyle history, and published methods to produce risk scores. This concept does not represent commercially approved tests or proven efficacy.
Does the website use EarlyGuard test kits or repeated biomarker measurements?
No. The public website profile check uses only information you enter and applicable published methods. It does not use EarlyGuard test-kit measurements, repeated or longitudinal biomarker history, or invented kit data. Any broader kit- and biomarker-based capability is part of the full EarlyGuard solution in clinical development, not this website experience.
Why is a result unavailable?
Each assessment is intended for a defined population and requires certain information. If required information is missing or your profile is outside the applicable population, the result will be unavailable. The tool does not fill in missing information or provide a result outside its intended use.
What happens to my data?
Your data is processed subject to explicit health consent and the platform's privacy practices. You can manage available data settings within your profile. Optional marketing consents are kept separate and are not required to use the analysis tools. Please review our Privacy Policy for detailed information.
How does AI help?
In this public website experience, AI is scoped to organizing the information you enter and explaining an available published-method result in clear language. It does not diagnose, make an independent medical decision, or replace your clinician's judgment. EarlyGuard-developed AI models are also part of the broader full-solution capability concept in clinical development, which is distinct from this limited website example. Your personal report provides the published method and source details.
How should I interpret a published method?
Published methods are validated only within their original study populations and settings. That validation does not validate the whole EarlyGuard platform or establish that the method applies to every user or country. Review the applicability notes in your report and discuss the result with a healthcare professional.
What about a prostate assessment?
If a prostate assessment is available, it relates to outcomes from a current, clinician-indicated biopsy. It does not predict your future prostate cancer risk. Discuss whether it is appropriate with the clinician recommending the biopsy.
Ready to try the website example?
Log in or create an account to complete your profile and try this limited website example. It is not the full EarlyGuard assessment or a diagnostic test.
Create your profile & try the example